Zentalis Pharmaceuticals, Inc. (ZNTL) Operating cash flow 2019–2025
Zentalis Pharmaceuticals, Inc. (ZNTL) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$125.2MFY2025 · since FY2019: -$39.1M → -$125.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$125.2M | +26.7% |
| FY2024 | -$170.9M | +17.8% |
| FY2023 | -$207.8M | -26.9% |
| FY2022 | -$163.8M | -6.3% |
| FY2021 | -$154.1M | -77.5% |
| FY2020 | -$86.8M | -121.8% |
| FY2019 | -$39.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice